Corrigendum to ‘Gut microbiota dysbiosis and neurologic diseases: New Horizon with potential diagnostic and therapeutic impact’

Corrigendum to ‘Gut microbiota dysbiosis and neurologic diseases: New Horizon with potential diagnostic and therapeutic impact’

Saved in:

Bibliographic Details
Main Authors:	Ali Keshavarzian, Sangram S. Sisodia
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Neurotherapeutics
Online Access:	http://www.sciencedirect.com/science/article/pii/S1878747924001892
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bisphenol S impairs oocyte quality by inducing gut microbiota dysbiosis
by: Jiaming Zhang, et al.
Published: (2025-01-01)

Irritable Bowel Syndrome: Gut Microbiota Dysbiosis and Psychological Co-morbidities
by: Bijita Bhowmick, et al.
Published: (2025-01-01)

Gut dysbiosis in primary sarcopenia: potential mechanisms and implications for novel microbiome-based therapeutic strategies
by: Wei Yang, et al.
Published: (2025-01-01)

Atg5 deficiency in basophils improves metabolism in lupus mice by regulating gut microbiota dysbiosis
by: Jiaxuan Chen, et al.
Published: (2025-01-01)

Erythropoietin supplementation induces dysbiosis of the gut microbiota and impacts mucosal immunity in a non-diseased mouse model
by: Guillaume Sarrabayrouse, et al.
Published: (2025-01-01)

Impact of Saccharomyces cerevisiae on the intestinal microbiota of dogs with antibiotic-induced dysbiosis
by: Sara Arghavani, et al.
Published: (2025-02-01)

Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain
by: Hao-Ming Xu, et al.
Published: (2021-01-01)

HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
by: Kishanda Vyboh, et al.
Published: (2015-01-01)

Combined BPA and DIBP Exposure Induced Intestinal Mucosal Barrier Impairment Through the Notch Pathway and Gut Microbiota Dysbiosis in Mice
by: Mengge Duan, et al.
Published: (2025-01-01)

Dysbiosis of Gastric Mucosal Fungal Microbiota in the Gastric Cancer Microenvironment
by: Zhenzhan Zhang, et al.
Published: (2022-01-01)

Beyond the microbiome: unraveling gut dysbiosis and its impact on systemic lupus erythematosus
by: Yara Safwat Roshdy, et al.
Published: (2025-12-01)

Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics
by: Grant McGee Talkington, et al.
Published: (2025-02-01)

AhR Activation Transcriptionally Induces Anti-Microbial Peptide Alpha-Defensin 1 Leading to Reversal of Gut Microbiota Dysbiosis and Colitis
by: Manikandan Palrasu, et al.
Published: (2025-12-01)

Warm and humid environment induces gut microbiota dysbiosis and bacterial translocation leading to inflammatory state and promotes proliferation and biofilm formation of certain bacteria, potentially causing sticky stool
by: Yinrui Guo, et al.
Published: (2025-01-01)

Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure
by: Qiujin Jia, et al.
Published: (2019-01-01)

Gut Dysbiosis and Abnormal Bile Acid Metabolism in Colitis-Associated Cancer
by: Li Liu, et al.
Published: (2021-01-01)

Gut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia
by: Anna Picca, et al.
Published: (2018-01-01)

Perturbations in gut microbiota composition in patients with autoimmune neurological diseases: a systematic review and meta-analysis
by: Xiaolin Deng, et al.
Published: (2025-02-01)

The Gut Microbiota Dysbiosis in Preeclampsia Contributed to Trophoblast Cell Proliferation, Invasion, and Migration via lncRNA BC030099/NF-κB Pathway
by: Rong Tang, et al.
Published: (2022-01-01)

Characteristics, pathogenic and therapeutic role of gut microbiota in immunoglobulin A nephropathy
by: Kaijin Yao, et al.
Published: (2025-02-01)

Gut-Lung Microbiota in Chronic Pulmonary Diseases: Evolution, Pathogenesis, and Therapeutics
by: Chang Yi Shi, et al.
Published: (2021-01-01)

Machine learning prediction of obesity-associated gut microbiota: identifying Bifidobacterium pseudocatenulatum as a potential therapeutic target
by: Hao Wu, et al.
Published: (2025-02-01)

Physiological and intestinal microbiota responses of sea cucumber Apostichopus japonicus to various stress and signatures of intestinal microbiota dysbiosis
by: Liang Cui, et al.
Published: (2024-12-01)

Obesity-Linked Gut Microbiome Dysbiosis Associated with Derangements in Gut Permeability and Intestinal Cellular Homeostasis Independent of Diet
by: Ravinder Nagpal, et al.
Published: (2018-01-01)

Broadening horizons: research on ferroptosis in lung cancer and its potential therapeutic targets
by: Guangpeng Gao, et al.
Published: (2025-01-01)

Microbial dysbiosis in periodontitis and peri-implantitis: pathogenesis, immune responses, and therapeutic
by: Ziwei Cui, et al.
Published: (2025-02-01)

The Role of Lower Airway Dysbiosis in Asthma: Dysbiosis and Asthma
by: Junying Lu, et al.
Published: (2017-01-01)

Dysbiosis of infant gut microbiota is related to the altered fatty acid composition of human milk from mothers with gestational diabetes mellitus: a prospective cohort study
by: Kelei Li, et al.
Published: (2025-12-01)

Exploring the associations of gut microbiota with inflammatory and the early hematoma expansion in intracerebral hemorrhage: from change to potential therapeutic objectives
by: Haixiao Jiang, et al.
Published: (2025-02-01)

Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation
by: Roos-Marijn Berbers, et al.
Published: (2025-01-01)

Corrigendum: Metabolic changes before and after weaning in Dezhou donkey foals in relation to gut microbiota
by: Qiwen Yang, et al.
Published: (2025-02-01)

Corrigendum: Effects of rosemary extract and its residue on production, immune performance, and gut microbiota in geese
by: Yuzhi Huang, et al.
Published: (2025-01-01)

The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights
by: Zhuo Huang, et al.
Published: (2025-01-01)

Emerging role of gut microbiota extracellular vesicle in neurodegenerative disorders and insights on their therapeutic management
by: Adil Hassan, et al.
Published: (2024-12-01)

The Potential Role of Gut Microbiota in the Prevention and Treatment of Lipid Metabolism Disorders
by: Yan-Jun He, et al.
Published: (2020-01-01)

Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials
by: Alqassem Y. Hakami, et al.
Published: (2025-02-01)

Editorial: Respiratory dysfunction in neurological disease and injury: novel mechanisms and potential therapeutics
by: Savannah Lusk, et al.
Published: (2025-01-01)

Dysbiosis and extraintestinal cancers
by: Ruishan He, et al.
Published: (2025-02-01)

Age-Stratified Analysis of Vaginal Microbiota Dysbiosis and the Relationship with HPV Viral Load in HPV-Positive Women
by: Mingzhu Li, et al.
Published: (2022-01-01)

Nature-Inspired Drugs: Expanding Horizons of Contemporary Therapeutics
by: Azhar Rasul, et al.
Published: (2019-01-01)